CY1108758T1 - Συνεργαζομενοι φορεις του τομεα ρτβ1 της fe65,παρασκευη και χρησεις - Google Patents

Συνεργαζομενοι φορεις του τομεα ρτβ1 της fe65,παρασκευη και χρησεις

Info

Publication number
CY1108758T1
CY1108758T1 CY20091100140T CY091100140T CY1108758T1 CY 1108758 T1 CY1108758 T1 CY 1108758T1 CY 20091100140 T CY20091100140 T CY 20091100140T CY 091100140 T CY091100140 T CY 091100140T CY 1108758 T1 CY1108758 T1 CY 1108758T1
Authority
CY
Cyprus
Prior art keywords
rtv1
sector
preparation
associated participants
present
Prior art date
Application number
CY20091100140T
Other languages
English (en)
Inventor
Isabelle Maury
Luc Mercken
Alain Fournier
Original Assignee
Aventis Pharma S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR0001628A external-priority patent/FR2804962B1/fr
Application filed by Aventis Pharma S.A. filed Critical Aventis Pharma S.A.
Publication of CY1108758T1 publication Critical patent/CY1108758T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Respiratory Apparatuses And Protective Means (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Soft Magnetic Materials (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)

Abstract

Η παρούσα εφεύρεση αφορά σε νέες ενώσεις και στην φαρμακευτική και διαγνωστική τους χρήση ή στην χρήση τους ως φαρμακολογικούς στόχους. Πιο συγκεκριμένα, η παρούσα εφεύρεση περιγράφει την ταυτοποίηση των συνεργαζόμενων φορέων της πρωτεΐνης FE65 και την χρήση αυτών, ή κάθε ένωσης ικανής να διαμορφώνει, τουλάχιστον εν μέρει, την αλληλεπίδραση τους με την FE65, προκειμένου να ρυθμίζει την δραστηριότητα της FE65, και κυρίως το φαινόμενο της ενδοκυτταρικής μεταφοράς ή της ενδοκυττάρωσης του ΑΡΡ.
CY20091100140T 2000-02-10 2009-02-05 Συνεργαζομενοι φορεις του τομεα ρτβ1 της fe65,παρασκευη και χρησεις CY1108758T1 (el)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0001628A FR2804962B1 (fr) 2000-02-10 2000-02-10 Partenaires du domaine ptb1 de fe65, preparation et utilisations
US19850000P 2000-04-18 2000-04-18
EP01907727A EP1257642B1 (fr) 2000-02-10 2001-02-07 Partenaires du domaine ptb1 de fe65, preparation et utilisations

Publications (1)

Publication Number Publication Date
CY1108758T1 true CY1108758T1 (el) 2014-04-09

Family

ID=26212162

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20091100140T CY1108758T1 (el) 2000-02-10 2009-02-05 Συνεργαζομενοι φορεις του τομεα ρτβ1 της fe65,παρασκευη και χρησεις

Country Status (17)

Country Link
US (2) US6696273B2 (el)
EP (1) EP1257642B1 (el)
KR (1) KR100802687B1 (el)
AT (1) ATE415476T1 (el)
AU (2) AU3562501A (el)
BR (1) BR0108247A (el)
CA (1) CA2399939A1 (el)
CY (1) CY1108758T1 (el)
DE (1) DE60136688D1 (el)
DK (1) DK1257642T3 (el)
ES (1) ES2315273T3 (el)
IL (1) IL151147A0 (el)
MX (1) MXPA02007620A (el)
NO (1) NO330798B1 (el)
NZ (1) NZ520697A (el)
PT (1) PT1257642E (el)
WO (1) WO2001059104A1 (el)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10146737A1 (de) * 2001-09-22 2003-04-10 Aventis Pharma Gmbh Coniosulfide und deren Derivate, Verfahren zu ihrer Herstellung und Verwendung als Arzneimittel

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0498827B1 (en) * 1989-11-02 2001-08-01 DictyTech Pty Limited Improved plasmid vectors for cellular slime moulds of the genus dictyostelium
US5928882A (en) * 1997-10-24 1999-07-27 The Rockefeller University Treatment and prevention of neurodegenerative diseases using modulators of Fe65
AU1536399A (en) * 1997-11-26 1999-06-15 Genetics Institute Inc. Secreted proteins and polynucleotides encoding them
US6214582B1 (en) * 1998-11-16 2001-04-10 The Research Foundation Of State University Of Ny Y2H35 a strong IKK binding protein

Also Published As

Publication number Publication date
CA2399939A1 (fr) 2001-08-16
IL151147A0 (en) 2003-04-10
KR100802687B1 (ko) 2008-02-12
NZ520697A (en) 2005-11-25
US6696273B2 (en) 2004-02-24
MXPA02007620A (es) 2002-12-13
PT1257642E (pt) 2009-01-30
US20020061553A1 (en) 2002-05-23
BR0108247A (pt) 2002-11-05
ATE415476T1 (de) 2008-12-15
AU2001235625B2 (en) 2007-01-11
EP1257642B1 (fr) 2008-11-26
NO330798B1 (no) 2011-07-18
WO2001059104A1 (fr) 2001-08-16
NO20023783D0 (no) 2002-08-09
DK1257642T3 (da) 2009-03-30
US6942982B2 (en) 2005-09-13
EP1257642A1 (fr) 2002-11-20
DE60136688D1 (de) 2009-01-08
US20040166109A1 (en) 2004-08-26
KR20020079844A (ko) 2002-10-19
NO20023783L (no) 2002-09-09
ES2315273T3 (es) 2009-04-01
AU3562501A (en) 2001-08-20

Similar Documents

Publication Publication Date Title
CY1119598T1 (el) Ανθεκτικες σε θραυση μορφες δοσολογησης με επιβραδυντικη απελευθερωση
ES2184149T3 (es) Paclitaxeles 6-tio sustituidos.
CY1119243T1 (el) Φαρμακοτεχνικες μορφες ανταγωνιστη του vegf
CY1106532T1 (el) Ετερολογος εκφραση των πρωτεϊνων της neisseria
CY1110225T1 (el) Κυκλικοι αναστολεις πρωτεϊνικης τυροσινικης κινασης
CY1110344T1 (el) Φαρμακευτικο σκευασμα περιεχον ενα αντισωμα εναντιον του υποδοχεα του επιδερμικου αυξητικου παραγοντα (egf)
NO995349D0 (no) Multivalent vaksinasjonssammensetning med blandet baerer
CY1105235T1 (el) Συνθεσεις λασοφοξιφενης
MX9204625A (es) Composicion farmaceutica para el tratamiento de una especie de mamifero, que sufre de deficiencia cardiaca congestiva.
CY1107841T1 (el) Φαρμακευτικα σκευασματα τα οποια περιλαμβανουν μυκοφαινολικο οξυ ή μυκοφαινολικο αλας
CY1111567T1 (el) Ενδιαμεσα διβενζο (b,f) αζεπινης
CY1108007T1 (el) Φαρμακευτικες συνθεσεις βοτουλινικης τοξινης
CY1109503T1 (el) Συνθεσεις βρεφικων τροφων που περιλαμβανουν αυξημενες ποσοτητες αλφα-λακταλβουμινης
BR9812634A (pt) April - uma proteìna com efeitos de crescimento
CY1108049T1 (el) Πεπτιδια με βαση την αλληλουχια της ανθρωπινης λακτοφερρινης και χρηση τους
ATE231872T1 (de) Thiazolopyrimidinderivate
ATE260650T1 (de) Orale darreichungsformen zur verabreichung einer fixen kombination von tramadol und diclofenac
TR199801739T2 (xx) Viral enfeksiyonlar�n tedavisinde flukonazol kullan�m�.
ATE186738T1 (de) Kohlenhydratmodifizierte cytostatika
CY1111509T1 (el) Ενωσεις με ιδιοτητες απελευθερωσης αυξητικης ορμονης
TR200200359T2 (tr) Cgrp Antagonist'lerinin ve cgrp-release (Gevşeme)-Engelleyici Menopoza Bağlı Deri Kızarıklıklarında Kullanılması
DE59902006D1 (de) Wirkstoffhaltige aromatische copolyester
SE9802937D0 (sv) Novel compounds
IT1270618B (it) Proteine ad attivita' antitumorale
TR200002101T2 (tr) Dondurulmuş gıda ürünü.